Abstract
A new vanadium (IV) complex with the monoanion of 2,3-dihydroxypyridine (H2dhp), or 3-hydroxy-2-(1H)-pyridone, was synthesized, characterized by physicochemical techniques and tested biologically. The EPR data for the [VO(Hdhp)2] complex in DMF are: g x = 1.9768, g y = 1.9768 and g z = 1.9390; A values (10−4 cm−1): A x , 59.4; A y//, 59.4; A z , 171.0. The νV=O band in the IR spectrum of the complex is at 986 cm−1. The complex is paramagnetic, with μeff = 1.65 BM (d1, spin-only) at 25 °C. The irreversible oxidation process [V(V)/V(IV)] of the [VO(Hdhp)2] complex, as revealed in a cyclic voltammogram, occurs at 876 mV. The calculated molecular structure of [VO(Hdhp)2] shows the vanadium(IV) center in a distorted square pyramidal environment, with the oxo ligand in the apical position and the oxygen donor atoms of the Hdhp ligands in the basal positions. The ability of [VO(Hdhp)2] to mimic insulin, and its toxicity to hepato-biliary functions, were investigated in streptozotocin-induced diabetic rats and it was concluded that the length of treatment and the amount of [VO(Hdhp)2] administered were effective in reducing experimental diabetes.
Similar content being viewed by others
References
International Diabetes Federation (2003) Diabetes Atlas, 2nd edn. 56 p. Available at: http://www.idf.org/home. Accessed on: 10 December, 2005
Farrel N (1989) Transition metal complexes as drugs and chemotherapeutic agents. Kluwer Academic Publishers, Dordrecht
Orvig C, Abrams MJ (1999) Chem Rev 99:2201
Kotoh A, Kazutoshi T, Okada H, Harata M, Fujisawa Y, Takino T, Sakurai H (2000) Chem Lett 29:866
Pepato MT, Magnani MRT, Kettelhut IC, Brunetti IL (1998) Rev Ciênc Farmac 19:93
Pepato MT, Magnani MRT, Kettelhut IC, Brunetti IL (1999) Mol Cell Biochem 198:157
Cohen N, Halberstam M, Shlimovich P, Chang CJ, Shamoon H, Rossetti L (1995) J Clin Invest 95:2501
Halberstam M, Cohen N, Shlimovich P, Rosset L, Shamoon H (1996) Diabetes 45:659
Boden G, Chen X, Ruiz J, van Rossum GD, Turco S (1996) Metabolism 45:1130
Heyliger CE, Tahiliani AG, McNeill JH (1985) Science 227:1474
Meyerovitch J, Farfel Z, Sack J, Shechter Y (1987) J Biol Chem 262:6658
Sakurai H, Tsuchiya K, Nukatsuka M, Kawada J, Sofue MM (1990) J Endocrinol 126:451
Nakai M, Watanabe H, Fujiwara C, Kakegawa H, Satoh T, Takada J, Matsushita R, Sakurai H (1995) Biol Pharm Bull 18:719
Tawa R, Uchida K, Taniyama J, Fujimoto S, Nagaoka T, Kanamori K, Sakurai H (1999) J Pharm Pharmacol 51:119
Thompson KH, Orvig C (2001) Chem Rev 219:1033
Yuen VG, Orvig C, McNeill JH (1993) Can J Physiol Pharmacol 71:270
Yuen VG, Pederson RA, Dai S, Orvig C, McNeill JH (1996) Can J Physiol Pharmacol 74:1001
Storr T, Mitchell D, Buglio P, Thompson KH, Yuen VG, McNeill JH, Orvig C (2003) Bioconjug Chem 14:212
Sálice CC, Cortizo AM, Gomez Dumm CL, Etcheverry SB (1999) Mol Cell Biochem 198:119
Sakurai H, Watanabe H, Tamura H, Yasui H, Matsushita R, Takada J (1998) J Inorg Chim Acta 283:175
Kordowiak AM, Dudek B, Grybós R (2000) Comp Biochem Physiol 125:11
Etcheverry SB, Williams PA, Barrio DA, Salice VC, Ferrer EG, Cortizo AM (2000) J Inorg Biochem 80:169
Melchior M, Rettig SJ, Liboiron BD, Thompson KH, Yuen VG, McNeill JH, Orvig C (2001) Inorg Chem 40:4686
Takeshita S, Kawamura I, Yasuno T, Kimura C, Yamamoto T, Seki J, Tamura A, Sakurai H, Goto T (2001) Inorg Biochem 85:179
Deflon VM, Bessler KE, Kretschmar M, Abram U (2000) Z Anorg Allg Chem 626:1545
de Souza EJ, de Fernandes AGA, Deflon VM, Bessler KE, Lemos SS, Batista AA, Ellena J, Castellano EE, Abram U, Hagenbach A (2006) J Braz Chem Soc 17:1578
Dubowski KM (1962) Clin Chem 8:215
Bergmeyer HU (1985) In: Methods of enzimatic analysis, vol 9. VCH, Florida
Bolleter WT, Bushman CJ, Tidwell PW (1961) Anal Chem 33:592
Bradford MM (1976) Anal Biochem 72:248
Hehre WJ, Yu J, Klunzinger PE, Lou L (1998) A Brief Guide to Molecular Mechanics and Quantum Chemical Calculations. Wavefunction Inc., Irvine CA
Spartan PC Pro v1.0.5, Wavefunction Inc., 18401 Von Karman Ave., Suite 370, Irvine, CA 92612 (http://www.wavefun.com)
da Maia PIS, Deflon VM, de Souza EJ, Garcia E, de Souza GF, Batista AA, de Figueiredo AT, Niquet E (2005) Trans Met Chem 30:404
Arulmozhi DK, Veeranjaneyulu A, Bodhankar SL (2004) Indian J Pharmacol 36:217
Mituruka BM, Rawnsley HM (1981) In: Clinical biochemistry and hematological reference values in normal experimental animals and normal humans. Masson Publishing USA, New York, pp 153–314
Smith TS, LoBrutto R, Pecoraro VL (2002) Coord Chem Rev 228:1
Hanson GR, Sun Y, Orvig C (1996) Inorg Chem 35:6507
El-Remessy AB, Al-Shabrawey M, Khalifa K, Tsai NT, Caldwell RB, Liou GI (2006) Am J Pathol 168:235
Sakurai H, Sano H, Takino T, Yasui H (2000) J Inorg Biochem 80:99
Tepperman J, Tepperman HM (eds) (1987) Endocrine function of the pancreas. In: Metabolic and Endocrine Physiology, 5th edn. Year Book Medical, Chicago, p 249
Hosaka EM, Santos OFP, Seguro AC (2004) Braz J Med Biol Res 37:979
Sakurai H, Shimomura S, Fukuzawa K, Ishizu K (1980) Biochem Biophys Res Commun 96:293
Degani H, Gochin M, Karlish SJD, Schechter Y (1981) Biochemistry 20:5795
Dai S, Thompson KH, Vera E, McNeill JH (1994) Pharmacol Toxicol 75:265
Mori DM, Baviera AM, Ramalho LTO, Vendramini RC, Brunetti IL, Pepato MT (2003) Biotechnol Appl Biochem 38:183
Zhou XW, Chen QX, Chen Z, Zhou HM (2000) Biochemistry 65:1424
Etcheverry SB, Barrio DA, Williams PA, Baran EJ (2001) Biol Trace Elem Res Winter 84:227
Acknowledgments
We wish to thank the Foundation for the Development of the University of the State of São Paulo (FUNDUNESP), the Scientific Research Aid Program of the Araraquara School of Pharmaceutical Sciences, UNESP (PADC-FCF-Araraquara-UNESP) and the São Paulo State Research Aid Foundation (FAPESP) for financial support. EJ de Souza, MC da Rocha and MF Alberconi are Postgraduate students. We are also grateful to Ms VCO Alves, Ms TN Nunes and Mr MA Dangona for their technical assistance.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Pepato, M.T., Alberconi, M.F., da Rocha, M.C. et al. Synthesis, characterization and biological analysis of the complex [VO(Hdhp)2] (H2dhp = 2,3-dihydroxypyridine). Transition Met Chem 33, 301–309 (2008). https://doi.org/10.1007/s11243-007-9003-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11243-007-9003-5